Skip to content

Shares (Diluted) at other companies

PBH
Prestige Consumer HealthcarePBH
48.7M-2.7%
Bausch + Lomb logo
Bausch + LombBLCO
355.2M+0.7%
Johnson & Johnson logo
Johnson & JohnsonJNJ
2.4B+0.9%
AbbVie logo
AbbVieABBV
1.8B+0.1%
Organon logo
OrganonOGN
262.9M+0.7%
HRO
HarrowHROW
37.2M+3.9%

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$1.79B-15.9%
Enterprise value$21.24B-5.6%
P/S0.2×0.0×

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch Health Companies's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch Health Companies's shares (diluted)?
Bausch Health Companies (BHC) reported shares (diluted) of 372.8M in Q1 2026.
How has Bausch Health Companies's shares (diluted) changed year-over-year?
Bausch Health Companies's shares (diluted) increased by 0.9% year-over-year, from 369.6M to 372.8M.
What is the long-term trend for Bausch Health Companies's shares (diluted)?
Over 4 years (2021 to 2025), Bausch Health Companies's shares (diluted) has grown at a 0.9% compound annual growth rate (CAGR), from 1.4B to 1.5B.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.